In January 2017, China’s State Council announced that the medical representative (MR) profession would be subject to two new requirements. One requirement was that all MRs must be registered on a government website to be able to conduct drug promotional activities, and the other was that MRs may not undertake “drug sales responsibilities.” In August, the Shanghai Food and Drug Association issued a draft regulation on MR registration to implement the State Council’s requirement, and a few other provinces and cities have followed suit. These regulations have drawn close attention from drug companies in China.
Sidley Austin LLP provides this information as a service to clients and other friends for educational purposes only. It should not be construed or relied on as legal advice or to create a lawyer-client relationship.
Attorney Advertising - For purposes of compliance with New York State Bar rules, our headquarters are Sidley Austin LLP, 787 Seventh Avenue, New York, NY 10019, 212.839.5300; One South Dearborn, Chicago, IL 60603, 312.853.7000; and 1501 K Street, N.W., Washington, D.C. 20005, 202.736.8000.